Copyright Reports & Markets. All rights reserved.

Europe NK Cell Therapy Industry Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 NK Cell Therapy Industry Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 NK Cell Therapies Market Performance (Volume)
      • 2.1.2 NK Cell Directed Antibodies Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 NK Cell Therapies Market Performance (Value)
      • 2.2.2 NK Cell Directed Antibodies Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Cancer Market Performance (Volume)
      • 3.1.2 Gastrointestinal Diseases Market Performance (Volume)
      • 3.1.3 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Nektar Therapeutics
      • 4.1.1 Nektar Therapeutics Profiles
      • 4.1.2 Nektar Therapeutics Product Information
      • 4.1.3 Nektar Therapeutics NK Cell Therapy Industry Business Performance
      • 4.1.4 Nektar Therapeutics NK Cell Therapy Industry Business Development and Market Status
    • 4.2 Innate Pharma SA
      • 4.2.1 Innate Pharma SA Profiles
      • 4.2.2 Innate Pharma SA Product Information
      • 4.2.3 Innate Pharma SA NK Cell Therapy Industry Business Performance
      • 4.2.4 Innate Pharma SA NK Cell Therapy Industry Business Development and Market Status
    • 4.3 Affimed
      • 4.3.1 Affimed Profiles
      • 4.3.2 Affimed Product Information
      • 4.3.3 Affimed NK Cell Therapy Industry Business Performance
      • 4.3.4 Affimed NK Cell Therapy Industry Business Development and Market Status
    • 4.4 Chipscreen Biosciences
      • 4.4.1 Chipscreen Biosciences Profiles
      • 4.4.2 Chipscreen Biosciences Product Information
      • 4.4.3 Chipscreen Biosciences NK Cell Therapy Industry Business Performance
      • 4.4.4 Chipscreen Biosciences NK Cell Therapy Industry Business Development and Market Status
    • 4.5 Fate Therapeutics
      • 4.5.1 Fate Therapeutics Profiles
      • 4.5.2 Fate Therapeutics Product Information
      • 4.5.3 Fate Therapeutics NK Cell Therapy Industry Business Performance
      • 4.5.4 Fate Therapeutics NK Cell Therapy Industry Business Development and Market Status
    • 4.6 Glycostem Therapeutics
      • 4.6.1 Glycostem Therapeutics Profiles
      • 4.6.2 Glycostem Therapeutics Product Information
      • 4.6.3 Glycostem Therapeutics NK Cell Therapy Industry Business Performance
      • 4.6.4 Glycostem Therapeutics NK Cell Therapy Industry Business Development and Market Status
    • 4.7 Dragonfly Therapeutics
      • 4.7.1 Dragonfly Therapeutics Profiles
      • 4.7.2 Dragonfly Therapeutics Product Information
      • 4.7.3 Dragonfly Therapeutics NK Cell Therapy Industry Business Performance
      • 4.7.4 Dragonfly Therapeutics NK Cell Therapy Industry Business Development and Market Status
    • 4.8 Kiadis Pharma
      • 4.8.1 Kiadis Pharma Profiles
      • 4.8.2 Kiadis Pharma Product Information
      • 4.8.3 Kiadis Pharma NK Cell Therapy Industry Business Performance
      • 4.8.4 Kiadis Pharma NK Cell Therapy Industry Business Development and Market Status
    • 4.9 NantWorks
      • 4.9.1 NantWorks Profiles
      • 4.9.2 NantWorks Product Information
      • 4.9.3 NantWorks NK Cell Therapy Industry Business Performance
      • 4.9.4 NantWorks NK Cell Therapy Industry Business Development and Market Status
    • 4.10 Nkarta Therapeutics
      • 4.10.1 Nkarta Therapeutics Profiles
      • 4.10.2 Nkarta Therapeutics Product Information
      • 4.10.3 Nkarta Therapeutics NK Cell Therapy Industry Business Performance
      • 4.10.4 Nkarta Therapeutics NK Cell Therapy Industry Business Development and Market Status
    • 4.11 Fortress Biotech

    5 Market Performance for Manufacturers

    • 5.1 Europe NK Cell Therapy Industry Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe NK Cell Therapy Industry Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe NK Cell Therapy Industry Market Performance (Sales Point)

    • 7.1 Europe NK Cell Therapy Industry Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe NK Cell Therapy Industry Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe NK Cell Therapy Industry Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe NK Cell Therapy Industry Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Cancer Industry
    • 11.2 Gastrointestinal Diseases Industry
    • 11.3 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe NK Cell Therapy Industry Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 NK Cell Therapies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 NK Cell Directed Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Cancer Sales and and Growth Rate 2021-2026
      • 12.3.3 Gastrointestinal Diseases Sales and and Growth Rate 2021-2026
      • 12.3.4 Others Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe NK Cell Therapy Industry Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe NK Cell Therapy Industry Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, the NK Cell Therapy Industry market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
    Sales and revenue by type/application from 2014-2026.
    Industry chain, market trend, downstream and upstream information is also included.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of NK Cell Therapy Industry for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe NK Cell Therapy Industry market competition by top manufacturers/players, with NK Cell Therapy Industry sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Nektar Therapeutics
    Innate Pharma SA
    Affimed
    Chipscreen Biosciences
    Fate Therapeutics
    Glycostem Therapeutics
    Dragonfly Therapeutics
    Kiadis Pharma
    NantWorks
    Nkarta Therapeutics
    Fortress Biotech

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    NK Cell Therapies
    NK Cell Directed Antibodies

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of NK Cell Therapy Industry for each application, including
    Cancer
    Gastrointestinal Diseases
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now